Michael A. Wappel

Michael Wappel practices at Monmouth Cardiology Associates in Eatontown, New Jersey.

Michael Wappel's NPI, 1356315873, was assigned on February 13, 2006. Michael Wappel graduated from Southern Illinois University School of Medicine in 1981. Michael Wappel holds New Jersey license 25MA04979700.

Michael Wappel's primary practice is Monmouth Cardiology Associates, at 11 Meridian Rd, Eatontown, NJ 07724 in Monmouth County. The practice phone is (732) 663-0300.

Michael Wappel's primary practice is Monmouth Cardiology Associates in Eatontown, New Jersey. Michael Wappel is also affiliated with Jersey Shore University Medical Center. The medical group on file is Monmouth Cardiology Associates. Dmand AI also links Michael Wappel to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Wappel practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Michael Wappel's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Michael Wappel is licensed in New Jersey.

CMS data shows 6,380 Medicare services from Michael Wappel across 21 procedure codes in 2024, for 1,986 Medicare patients. Medicare paid $515,513 for them.

CMS counts 1,986 Medicare patients who saw Michael Wappel in 2024. The largest group is 75 to 84, with 754 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Wappel's median patient age at 69, with 43% women.

In 2024, Michael Wappel wrote 3,731 Medicare Part D claims for 506 patients. 85% of them were for generic drugs. CMS names the drug for 3,509 of them, across 50 drugs with 11 or more claims each, at $918,745 in total drug cost. In 2023, CMS named 2,965 claims across 44 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Michael Wappel for performance year 2024, reported as part of a group. Michael Wappel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 33 general payments to Michael Wappel from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbott Laboratories paid the most, $106.

Michael Wappel graduated from Southern Illinois University School of Medicine in 1981.